Revenue Dynamics YoY (Last Twelve Months): Procaps Group S.A. (PROC)

Brandmark of Procaps Group S.A. (PROC)

The annual sales growth rate over a 12-month period on the GURU.Markets chart reflects a trend where -4.70 becomes the new value for this metric for Procaps Group S.A. (PROC). This growth is driven by unique capsule patents and stringent FDA regulations, while stability is underpinned by sophisticated equipment and expertise in Latin America. Meanwhile, management is currently focusing on reporting transparency and the implementation of compliance measures to restore investor confidence.

Procaps Group SA (PROC) Sales Growth YoY (TTM): for the period 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for Procaps Group S.A. (PROC)

- share price and consensus valuation forecast:
Quote Chart Procaps Group Corp|PROC - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Procaps Group S.A.|PROC - Total Company Value
- book capitalization information:
Net Asset Value per Share Procaps|PROC - Book Capitalization|Market Cap to Net Assets Ratio procapsgroup.com|PROC - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Procaps Group S.A.|PROC - Long-Term Debt to Equity|Current Liabilities to Equity Procaps Group|PROC - Company Debts|Debts to Net Assets Procaps Group SA|PROC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Procaps|Critical Liquidity procapsgroup.com
- earnings and market multiples details:
PROC - Company Net Income|Expected Net Income Procaps Group S.A.|PROC - Price to Earnings Ratio|Projected Price to Earnings Ratio Procaps|PROC - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Procaps Group S.A.|PROC - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Procaps|PROC - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months procapsgroup.com|PROC - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Procaps Group S.A.
- sales revenue and business income indicators:
PROC - Company Sales|Company Future Sales Procaps Group SA|PROC - P/S Multiple|Forward P/S Multiple Procaps Group SA|PROC - Revenue Growth YoY (Last 12 Months)
Analysis of all company metrics:PROC Procaps Group S.A.
Original product of Procaps Group Corp

To objectively assess Procaps Group S.A. (PROC), it is necessary to analyze revenue dynamics through the lens of debt load to avoid asset impairment. Comparable year-over-year sales growth over 12 months captures the daily change in annual revenue increase, reflecting the demand for unique Softgel technologies in the production of drugs for pharma behemoths and confirming the market resilience of this manufacturing ecosystem.

Competitor analysis for Procaps Group S.A.

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|Eupraxia Pharmaceuticals - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) BioHarvest Sciences Inc. BHST|EXOZ: Sales Growth YoY (TTM)|Oramed (ORMP) - Sales Growth YoY (TTM)|ENTX (Entera Bio) - Sales Growth YoY (TTM)|ipatherapeutics.com (HYFT) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Trailing Twelve Months Revenue Growth|TELO: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Sales Growth YoY (Last Twelve Months)|RLYB - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Lexaria Bioscience|Pulmatrix Corp - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) LYRA (Lyra Therapeutics Inc.)|Annual Revenue Growth (Last Twelve Months) Impact BioMedical (IBO)|TNF Pharmaceuticals - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cbdMD Inc.|PainReform Ltd. (PRFX) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Altamira Therapeutics (CYTO)|Sales Growth YoY (Last Twelve Months) Lipella Pharmaceuticals, Inc.|OPTN: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Pieris (PIRS)|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)